A couple’s complaint did not plausibly state a claim against 93 heparin defendants, a federal court in Washington state ruled June 13, dismissing the suit but allowing the plaintiffs to amend their complaint to allege which defendant or defendants manufactured the blood thinner that caused the wife’s injuries (McFarland v. APP Pharmaceuticals LLC., W.D. Wash., 2:10-cv-01746-RSL, 6/13/11).
In allowing the amendment, the U.S. District Court for the Western District of Washington said the complaint was timely under Washington’s discovery rule.
Laurel McFarland was given multiple doses of heparin during an October 2007 hospitalization. She developed heparin-induced thrombocytopenia ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.